论文信息 - SU2C phase Ib study of pan-PI3K inhibitor BKM120 with letrozole in ER+/HER2- metastatic breast cancer (MBC). - 字舞流文

SU2C phase Ib study of pan-PI3K inhibitor BKM120 with letrozole in ER+/HER2- metastatic breast cancer (MBC).

E. Winer | J. Yap | J. Balko | M. Sanders | C. Arteaga | S. Isakoff | I. Mayer | V. Abramson | Yisheng Li | M. Kuba | A. Forero-Torres | A. Abbeele | Stand Up to Cancer Pi K in Women's Cancers | A. D. Abbeele